Phillip Farmer
Director of Cancer Informatics
Also affiliated: Winthrop Rockefeller Foundation (2024); Erasmus MC Cancer Institute (2019)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Phillip Farmer's research focuses on the application of computational methods and advanced imaging techniques to understand and treat diseases. He has published work on the development of DICOM datasets for de-identification and evaluation of medical images, as well as automated skeleton segmentation from CT images. His work also investigates high-risk transcriptional profiles in multiple myeloma, exploring the role of the PRC2 complex, cell cycle progression, and divergent evolutionary pathways within molecular subgroups. Farmer has also explored the feasibility of telemedicine for research visits, particularly in populations with Parkinson's disease residing in medically underserved areas. His research network includes collaborators such as Michael Rutherford, Fred Prior, Michael Bauer, and Christopher P. Wardell, with whom he has co-authored multiple publications. Farmer's scholarship metrics include an h-index of 8, with 32 total publications and 272 citations.
Metrics
- h-index: 8
- Publications: 32
- Citations: 279
Selected Publications
-
How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence (2025)
-
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study (2025)
-
Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images (2025)
-
CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients (2024)
-
Feasibility of regional center telehealth visits utilizing a rural research network in people with Parkinson’s disease (2024)
-
Feasibility of telemedicine research visits in people with Parkinson’s disease residing in medically underserved areas (2022)
-
Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups (2021)
-
High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse (2021)
-
A DICOM dataset for evaluation of medical image de-identification (2021)
-
Chest imaging representing a COVID-19 positive rural U.S. population (2020)
-
Late Relapsing Multiple Myeloma ≥ 10 Years after Treatment on Total Therapy Protocols Are Associated with Good Outcome (2020)
-
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials (2020)
-
EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab (2019)
-
PF606 ADVERSE IMPACT OF PRIOR THERAPY ON TRANSPLANT OUTCOME IN MULTIPLE MYELOMA (2019)
-
Global Expression Changes of Malignant Plasma Cells over Time Reveals the Evolutionary Development of Signatures of Aggressive Clinical Behavior (2018)
Collaboration Network
Top Collaborators
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
- The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
- A DICOM dataset for evaluation of medical image de-identification
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence
- The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence
- The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
- A DICOM dataset for evaluation of medical image de-identification
- Feasibility of telemedicine research visits in people with Parkinson’s disease residing in medically underserved areas
- Feasibility of regional center telehealth visits utilizing a rural research network in people with Parkinson’s disease
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
Similar Researchers
Based on overlapping research topics